updated: 5/7/2007 1:53:38 PM
Governor Mitch Daniels, Secretary of Commerce Nathan Feltman, along with representatives from Purdue University and Indiana University are touting the state's life sciences in Boston today. They will be attending the BIO International Convention, which is the world's largest biotechnology trade show. The governor will tonight host 120 life sciences companies and venture capitalists at a dinner.
Source: Inside INdiana Business
Governor, IEDC Press Release
INDIANAPOLIS (May 4, 2007) — Governor Mitch Daniels and Secretary of Commerce Nathan Feltman will join Indiana’s top life sciences executives and academics Monday in Boston to recruit new high-tech companies to Indiana.
The trip is part of the state’s business recruiting efforts at the world’s largest biotechnology trade show, BIO International Convention 2007.
“We’re working every day to make Indiana a premier destination for life sciences companies, and we’re always eager to let more people know what we have to offer,” said Governor Mitch Daniels.
In addition to meeting one-on-one with company executives to encourage them to locate high-tech businesses here, the Governor will host a “Hoosier Comeback” luncheon for more than 100 former Hoosiers who live and work in the Boston area. That effort, he said, is aimed at attracting those who may have left the state in hopes of new opportunities but haven’t forgotten their Hoosier roots.
“Alumni from Indiana’s colleges and universities represent a phenomenal resource for life sciences companies and ultimately the Indiana economy,” said Feltman. “While many of them remember the unmatched quality of life here, they haven’t witnessed our economic comeback. By sharing our story, they undoubtedly will see the opportunities that lie ahead in the Hoosier state.”
The Governor will also host a dinner for more than 120 company executives and venture capitalists Monday evening keynoted by Eli Lilly and Company Executive Dr. Thomas Bumol.
This is the second consecutive year that Governor Daniels has attended the conference to bring new life sciences jobs to Indiana.
The state has scored three major life sciences announcements this year. In March, medical software provider Maaguzi announced its decision to consolidate its North American operations, a move that will create 42 new high-tech jobs in Central Indiana. U.K-based Oxford BioSignals Medical also announced its plans in March to locate its global life science headquarters in Carmel, bringing 120 new high-tech jobs to the Indianapolis suburb. In January, Beckman Coulter announced it would relocate its California-based life sciences operations to Central Indiana, bringing with it 212 new high-tech jobs. In 2006, Pfizer announced its plans to add 450 new employees to pharmaceutical manufacturing facility in Terre Haute and orthopedic device manufacturer Biomet announced a $21 million expansion that is expected to create more than 250 life science jobs in Warsaw.
Indiana is home to a $13.6B global life sciences industry that includes such life science leaders as Eli Lilly and Company, Cook, Inc., Roche Diagnostics and Dow AgroSciences. Battelle Memorial Institute named Indiana one of the nation’s top four life science leaders in terms of the number and concentration of life science jobs in 2006.
About Bio International Convention
Hosted by BIO, the world's largest biotechnology organization, the convention is the industry's signature annual event, attracting more than 20,000 biotechnology executives, scientists, policymakers and journalists from around the world. This year's May 6-9 convention in Boston is expected to be more than double the size of the last BIO convention in that city, held in 2000. For more information on the convention, visit www.Bio2007.org
The Indiana Economic Development Corporation is the state’s premier entity charged with economic development. The IEDC has a 12-member board chaired by Governor Mitch Daniels. Indiana Secretary of Commerce Nathan Feltman is also chief executive officer of the IEDC.
Source: Indiana Economic Development Corp.
Purdue University Press Release
BOSTON - The Purdue Research Park and Discovery Park will highlight how they are working together to advance research and spark economic development in the life sciences arena as a part of this month's BIO 2007 international conference.
Slated for Sunday through Wednesday (May 6-9) in Boston, the annual event is sponsored by the Biotechnology Industry Organization and is expected to draw 18,000 corporate executives, researchers, government officials and venture capitalists for three days of networking and learning.
BIO 2007 - with the theme New Ideas. Bold Ventures. Global Benefits. - also features more than 180 educational sessions and workshops on finance, partnerships, research and development, science, and policy.
"Through the expanding link between the Purdue Research Park and Discovery Park, Purdue is changing how a 21st century university translates research into viable commercial products to create jobs, grow our life sciences industry and spark the economy," said Joseph B. Hornett, senior vice president, treasurer and chief operating officer for the Purdue Research Foundation, which owns and operates Purdue Research Park.
"We also think BIO 2007 will be abuzz with excitement surrounding the announcement in March that the $100 million Alfred Mann Institute for Biomedical Development will be based at Purdue's Discovery Park, creating a new national model for commercializing intellectual property."
The Purdue Research Park, located near Purdue's main campus, is home to 140 companies and more than 2,900 employees working in the areas of tissue engineering, biomedical diagnostic devices, targeted drug delivery and nerve regeneration.
Discovery Park works closely with the Purdue Research Park as the university's primary interdisciplinary hub for research to build a stronger pipeline for translating campus research into commercial enterprises and startup companies.
The recently announced Alfred Mann Institute for Biomedical Development is designed to enable commercialization of innovative biomedical technologies that improve human health.
"The mission of this global conference centers on highlighting best practices to strengthen biotechnology innovation and progress," said Charles Buck, operations director at Discovery Park's Bindley Bioscience Center. "Through research advancements in biofuels, biomedicine, biopharmaceuticals and biotechnology at Discovery Park and its pipeline to the Purdue Research Park, Purdue is well-positioned for the amazing progress occurring in the biotechnology industry as well as its endless future potential."
Purdue's research expenditures in the life sciences area accounted for $166 million of the university's $365 million total during the 2005-2006 fiscal year. Over the last three years, life sciences research expenditures alone totaled $475 million.
The stakes also are high for Indiana.
In a recent report by technology giant Battelle Memorial Institute and BIO, Indiana was one of only three states with a specialization in three key life science sectors in 2006. Only New Jersey ranked higher, with a presence in all four sectors - agricultural feedstock and chemicals, drugs and pharmaceuticals, medical devices and equipment, and research testing and medical laboratories.
The state has an estimated 670 life science companies, employing more than 48,000 people and accounting for a total employment impact of 223,292 jobs. The average annual salary is $68,715, ranking among the highest of any industry in the state.
At BIO 2007, the Purdue booth (No. 2813) will highlight the work of several of the park's flagship life science companies, including Quadraspec Inc., BioVittesse Inc., Seyet Inc., Endocyte Inc., Bioanalytical Systems Inc., and the Chao Center for Industrial Pharmacy & Contract Manufacturing.
In addition, Purdue will display the park's business development acceleration services and its lineup of biotechnology companies in West Lafayette and the park's satellite incubators in Indianapolis, Merrillville, Ind., and New Albany, Ind.
Purdue will spotlight projects, research and facilities related to the life sciences field from Discovery Park's Bindley Bioscience Center, Birck Nanotechnology Center, Oncological Sciences Center, Burton D. Morgan Center for Entrepreneurship, Energy Center, e-Enterprise Center and the Regenstrief Center for Healthcare Engineering.
Two leading Purdue researchers also will sit on panel discussions during the conference.
Fred Regnier, the J.H. Law Distinguished Professor and a Bindley Center researcher, will participate in a discussion titled "Proteomics: A Strategy for Translating Discoveries to the Cancer Clinic," from 4-5:30 p.m. Monday (May 7). Regnier, an expert in analytical chemistry and biochemistry, is known for his efforts in proteomics, the pioneering field of categorizing protein function, and for developing a way to place multiple mini-labs on a single silicon chip.
Michael Ladisch, distinguished professor of agricultural and biological engineering and director of the Laboratory of Renewable Resources Engineering, will join a discussion on "Leading Pretreatment Technologies With Corn Stover and Poplar Wood" from 2-3:30 p.m. Tuesday (May 8). His research addresses bioprocess engineering, and his work has resulted in new industrial bioenergy processes and novel methods to transform renewable resources into bioproducts.
The Indiana Economic Development Corp., working in tandem with the state's life sciences initiative BioCrossroads, is sponsoring a luncheon and dinner on Monday (May 7) at BIO 2007 to draw attention to the state's national leadership role in the life sciences arena. Purdue also will have a display at the IEDC?s exhibit.
More than 90 technology-related companies call the Purdue Research Park home. Under development by the Purdue Research Foundation, a private, nonprofit foundation created to assist Purdue, the 591-acre research park also lays claim to the largest university-affiliated, business incubation complex in the country.
Discovery Park is a $350 million research hub at Purdue, fostering interdisciplinary research in health care, nanotechnology, alternative energy, homeland security, life sciences, cyberinfrastructure, advanced manufacturing, cancer treatment, systems engineering, the environment and innovative learning.
In its first five years, 16 companies have been launched based on research developed at Discovery Park, and most of those startups are now at the Purdue Research Park. Discovery Park also has generated more than $180 million worth of sponsored research for Purdue that has generated more than 40 patents.
The Biotechnology Industry Organization (BIO), which was founded in 1993, is a nonprofit association that represents more than 1,100 biotechnology companies, state and international affiliates, and related organizations.
Source: Purdue University